Notice2024-15391
Advisory Council on Blood Stem Cell Transplantation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 15, 2024
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Council on Blood Stem Cell Transplantation (ACBSCT or Advisory Council) has scheduled public meetings. Information about the Advisory Council and the agenda for these meetings can be found on the ACBSCT website at https:// bloodstemcell.hrsa.gov/about/advisory-council.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 135 (Monday, July 15, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 135 (Monday, July 15, 2024)]
[Notices]
[Page 57419]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-15391]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Council on Blood Stem Cell Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Council on Blood Stem Cell
Transplantation (ACBSCT or Advisory Council) has scheduled public
meetings. Information about the Advisory Council and the agenda for
these meetings can be found on the ACBSCT website at <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
DATES: Thursday, August 22, 2024, 2:00 p.m.-6:00 p.m. Eastern Standard
Time; and Thursday, October 24, 2024, 2:00 p.m.-6:00 p.m. Eastern
Standard Time.
ADDRESSES: Both meetings will be held virtually by webinar. A link to
register and join each meeting will be posted at least 10 days prior to
the meeting date at: <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal
Official, HRSA Health Systems Bureau, Division of Transplantation, 5600
Fishers Lane, 8W-67, Rockville, Maryland 20857; 301-443-8036; or
<a href="/cdn-cgi/l/email-protection#c18082839282958993928081a9b3b2a0efa6aeb7"><span class="__cf_email__" data-cfemail="b6f7f5f4e5f5e2fee4e5f7f6dec4c5d798d1d9c0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations
to the Secretary of Health and Human Services on policy, program
development, and other matters of significance concerning the
activities under the authority of 42 U.S.C. 274k (Section 379 of the
Public Health Service Act), as amended, and Public Law 109-129, as
amended. The Advisory Council may transmit its recommendations through
the HRSA Administrator on matters related to the activities of the C.W.
Bill Young Cell Transplantation Program and National Cord Blood
Inventory.
The agenda for the August 22, 2024, meeting is being finalized and
may include the following topics: criteria for defining a high-quality
cord blood unit for banking specifications; the unmet needs in blood
stem cell transplantation and cellular therapy; updates on transplant
outcomes by different donor sources; strategies to improve rates of
donation for adult blood stem cell donors; and other areas to increase
blood stem cell donation and transplantation. The agenda for the
October 24, 2024, meeting will be determined based on discussion,
priorities, and/or action items from the August 22, 2024, meeting. All
agenda items will be posted on the Advisory Council's website no later
than 10 days prior to the respective meeting dates. Agenda items are
subject to change as priorities dictate. Interested individuals are
encouraged to monitor the Advisory Council's website for any updated
information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meetings; oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACBSCT should be
sent to Shelley Tims Grant, using the contact information above, at
least 3 business days prior to the meeting.
Individuals who plan to attend and need special assistance or other
reasonable accommodations should notify Advisory Council at the address
and phone number listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-15391 Filed 7-12-24; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 15, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.